menu
    • menu

    Looking for excipients offered by DKSH? Find information on DKSH's regulatory filings (DMFs), cGMP inspections, pricing availability, etc. on PharmaCompass.

    DKSH-PSE
    News
    DKSH Earns Third Consecutive EcoVadis Gold Medal

    20 Dec 2025

    // PRESS RELEASE

    DKSH Technology Signs Biomedic Acquisition in Vietnam

    17 Dec 2025

    // PRESS RELEASE

    DKSH Acquires Invita, Scaling ANZ Food & Beverage Reach

    11 Dec 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    DKSH

    Contact Supplier

    Website

    Global ChemShow

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://www.youtube.com/embed/Z2h5A9ppOSo

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    EXCIPIENTS

    Key Products KEY EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Related CompaniesRelated Companies

    About

    DKSH, founded to improve lives, helps businesses expand in existing and emerging markets. With over 155 years of experience, it operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and reported CHF 11.1 billion net sales in 2021. DKSH is the leading global distributor of innovative pharma ingredients, offering products from APIs and excipients to animal care, intermediates, nutraceuticals, and packaging materials. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DKSHSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Wiesenstrasse 8, P.O. Box 888 Zurich, Zurich 8034, CH
    Telephone
    Telephone
    +49 4037473411
    Client Email
    Email
    rio.chang@dksh.com
    Client Website
    Website
    https://www.dkshdiscover.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dksh
    youtube
    YouTube
    http://www.youtube.com/@DkshGroup
    Twitter
    Twitter
    https://x.com/dkshgroup
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-34131.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-29458.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Performance Materials Brochure 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-13675.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea

    FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea

    Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of various conditions such as cancer, autoimmune diseases, and chronic illnesses. In 2023, eight out of 10 of the world’s top-selling drugs were biologics, including Merck’s Keytruda, AbbVie’s Humira, and Sanofi’s Dupixent.Due to their high costs, accessibility of biologics has been a challenge. That’s why biosimilars, or game-changing copycats of biologics that provide highly similar yet more affordable alternatives to established biologics, are becoming popular.The first biosimilar — Sandoz’ Zarxio — was approved by the US Food and Drug Administration (FDA) in 2015. Its reference biologic was Amgen’s Neupogen (filgrastim).  Since then, the global market for biosimilars has been growing at an impressive pace — between 2015 and 2020, it grew at a whopping compounded annual growth rate (CAGR) of 78 percent, touching US$ 17.9 billion in size. It is expected to continue growing at a CAGR of 15 percent and reach a size of about US$ 75 billion by 2030.Major biosimilar players include Amgen, Sandoz, Samsung Bioepis, Pfizer, Biocon Biologics, Celltrion, Stada Arzneimittel, Accord Healthcare, Fresenius Kabi, Coherus Biosciences, Apotex, and Sanofi. The increasing demand for biosimilars has propelled growth in contract manufacturing. Some of the leading contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that manufacture biosimilars are Polpharma Biologics, Catalent, Pfizer CentreOne, Lonza, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, WuXi Biologics, and FUJIFILM Diosynth Biotechnologies.Access the Interactive Dashboard for Biosimilar Developments (Free Excel)Amgen, Sandoz top list of ‘approved biosimilars’; FDA okays 8 copycats in H1 2024Over the recent years, regulatory agencies like the FDA and the European Medicines Agency (EMA) have established rigorous approval pathways for biosimilars.Since 2015,  FDA has approved 53 biosimilars, while the EMA has approved 86 biosimilars. Among the US, European and Canadian markets, Amgen and Sandoz are tied in the first place with 13 approved biosimilars each. Samsung Biologics has nine approved biosimilars, followed by Pfizer with eight and Biocon Biologics with seven. In the first half of this year, FDA set a record by approving eight biosimilars — the highest for H1 of any year. EMA has okayed six biosimilars so far in 2024.In 2023, five biosimilars were approved by the FDA with just one being okayed in the first half. The year marked the end of exclusivity for Humira after 20 years, in which it netted a total of US$ 200 billion in sales. AbbVie’s flagship autoimmune drug has a record 10 biosimilars.Johnson & Johnson’s Stelara also lost exclusivity in 2023 and as many as 11 drugmakers hope to bring its biosimilars to the market. Amgen’s Wezlana was the first biosimilar to Stelara, and it was approved as interchangeable by FDA in October last year.Access the Interactive Dashboard for Biosimilar Developments (Free Excel) FDA approves first interchangeable biosimilar for Eylea, cuts regulatory feeDeveloping a biosimilar costs both money and time. According to Pfizer, developing a biosimilar can take five to nine years and cost over US$ 100 million, not including regulatory fees.In October 2023, FDA slashed its fees with the program fee at US$ 177,397, down from US$ 304,162. The application fees for products that require clinical data has been set at US$ 1,018,753, down from US$ 1,746,745. The application fee for products that don’t require clinical data has been set lower — at US$ 509,377 —  down from US$ 873,373 set earlier. This reduction in application fee has propelled demand for contract manufacturing of biosimilars.There has also been a rise in approvals of interchangeable biosimilars this year. Interchangeable biosimilars meet additional requirements and may be substituted for its reference product by a pharmacist without consulting the prescriber. This year saw FDA approve the first interchangeable biosimilars for bone cancer drug denosumab (Prolia and Xgeva) in Jubbonti and Wyost as well as for eculizumab (Soliris) in Bkemv.In May, FDA approved the first interchangeable biosimilars for eye drug aflibercept (Eylea) in Opuviz and Yesafili. Other biosimilars approved in 2024 include Simlandi for adalimumab (Humira), Tyenne for tocilizumab (Actemra), Selarsdi for ustekinumab (Stelara), and Hercessi for trastuzumab (Herceptin).Access the Interactive Dashboard for Biosimilar Developments (Free Excel) Merck’s Keytruda, BMS’ Opdivo, Novartis’ Cosentyx brace for biosimilar competitionHealthcare spending in the US is projected to rise from US$ 4.5 trillion in 2022 to US$ 6 trillion by 2027. While biologics involve just two percent of prescriptions, they account for 46 percent of all pharmaceutical spending. In 2022, US$ 252 billion was spent on biologics.Biosimilar-related savings in 2023 were estimated to be US$ 9.4 billion in the US and € 10 billion (US$ 10.68 billion) in Europe. With expensive and widely used drugs like AbbVie’s Humira, J&J’s Stelara, and Regeneron’s Eylea coming under competition, US savings are projected to reach US$ 181 billion through 2027. Between 2026 and 2032, about 39 blockbusters are set to lose exclusivity in the US and Europe. Merck’s Keytruda (pembrolizumab) was the world’s top-selling drug last year, generating US$ 25 billion in sales. Its patent is set to expire in 2028 with sales expected to drop 19 percent to US$ 27.4 billion in 2029 from US$ 33.7 billion the previous year. Samsung Bioepis and Amgen initiated phase 3 trials of pembrolizumab in April and May of this year, respectively.Opdivo (nivolumab), belonging to the same class of drugs, competes with Keytruda and is also set to lose patent protection in 2028. It hauled in US$ 10 billion in total global sales in 2023 for Bristol Myers Squibb. The key patents of Novartis’ Cosentyx (secukinumab) are set to expire between 2025 and 2026. Cosentyx saw sales of US$ 5 billion in 2023. Taizhou Mabtech Pharmaceutical and Bio-Thera Solutions are conducting phase 3 trials of secukinumab.Access the Interactive Dashboard for Biosimilar Developments (Free Excel) Our viewWith over 2 billion people worldwide unable to access life-saving medicines, biosimilars hold the key to healthcare accessibility. In 2023, a record 13 biosimilars were launched in the market — the highest for a single year. And this included nine much-anticipated biosimilars to AbbVie’s Humira.  In April this year, FDA announced a Biosimilars Action Plan to streamline the development of biosimilars. With a sharp focus on biosimilars, we expect more records to be broken in the near term. New launches of biosimilars to drugs like J&J’s Stelara, Regeneron’s Eylea and Merck’s Keytruda will surely help in creating new records.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3816

    https://www.pharmacompass.com/radio-compass-blog/fda-approves-record-eight-biosimilars-in-h1-2024-okays-first-interchangeable-biosimilars-for-eylea

    #PharmaFlow by PHARMACOMPASS
    27 Jun 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    DKSH Earns Third Consecutive EcoVadis Gold Medal
    DKSH Earns Third Consecutive EcoVadis Gold Medal

    20 Dec 2025

    // PRESS RELEASE

    https://mailing-ircockpit.eqs.com/crm-mailing/5be9d1b2-ea7c-11e8-902f-2c44fd856d8c/241a4eb9-d658-4287-9737-0867c625baca/ccaea061-e24d-4255-b4fd-1ffc90545208/20250416_Media+Release_Ecovadis+Gold.pdf

    PRESS RELEASE
    20 Dec 2025
    Share Share
    DKSH Technology Signs Biomedic Acquisition in Vietnam
    DKSH Technology Signs Biomedic Acquisition in Vietnam

    17 Dec 2025

    // PRESS RELEASE

    https://www.dksh.com/in-en/home/investors/investor-news/dksh-technology-signs-biomedic-acquisition-in-vietnam

    PRESS RELEASE
    17 Dec 2025
    Share Share
    DKSH Acquires Invita, Scaling ANZ Food & Beverage Reach
    DKSH Acquires Invita, Scaling ANZ Food & Beverage Reach

    11 Dec 2025

    // PRESS RELEASE

    https://mailing-ircockpit.eqs.com/crm-mailing/5be9d1b2-ea7c-11e8-902f-2c44fd856d8c/241a4eb9-d658-4287-9737-0867c625baca/9ca1c6ae-a407-4f23-bf5f-846f08687b30/20251211_Media+Release_Invita.pdf

    PRESS RELEASE
    11 Dec 2025
    Share Share
    DKSH to Buy Out Malaysia Subsidiary and Delist from Bursa
    DKSH to Buy Out Malaysia Subsidiary and Delist from Bursa

    09 Dec 2025

    // PRESS RELEASE

    https://mailing-ircockpit.eqs.com/crm-mailing/5be9d1b2-ea7c-11e8-902f-2c44fd856d8c/241a4eb9-d658-4287-9737-0867c625baca/818bceeb-6e96-4e8b-aa0e-f2b3a32bd554/20251209_Media+Release_DHMB.pdf

    PRESS RELEASE
    09 Dec 2025
    Share Share
    DKSH Appoints Patrik Grande as new Head Business Unit Healthcare
    DKSH Appoints Patrik Grande as new Head Business Unit Healthcare

    21 Nov 2025

    // PRESS RELEASE

    https://www.dksh.com/in-en/home/investors/investor-news/dksh-appoints-patrik-grande-as-new-head-business-unit-healthcare

    PRESS RELEASE
    21 Nov 2025
    Share Share
    DKSH Performance Materials Attains EcoVadis Gold Rating
    DKSH Performance Materials Attains EcoVadis Gold Rating

    02 Oct 2025

    // PRESS RELEASE

    https://mailing-ircockpit.eqs.com/crm-mailing/b6ed963f-ce04-1015-9d5d-b20517257b19/dc35c44f-3ce8-4a5c-b125-6313dbe9b364/a963e751-e7d7-44b1-a3cb-fd8f9a78dce9/DKSH+Media+Release_DKSH+Performance+Materials+Attains+EcoVadis+Gold+Rating+for+its+Sustainability+Achievement.pdf

    PRESS RELEASE
    02 Oct 2025
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Excipients

    Discover the DDS // excipients from this company

    KEY EXCIPIENTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    DKSH full-view
    Blanose CMC 7LP EP
    full-view
    Blanose CMC 7LP EP
    full-view
    Aquapol® SF-1
    full-view

    Excipients by Ingredients

    Discover their expertise by components

    Excipients By applications

    Discover their expertise by claims

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact DKSH and get a quotation

    DKSH is a supplier offers 119 products (APIs, Excipients or Intermediates).

    Find a price of Acemetacin bulk offered by DKSH

    Find a price of Ajmaline bulk offered by DKSH

    Find a price of Alpha Lipoic Acid bulk offered by DKSH

    Find a price of Aluminium Hydroxide bulk offered by DKSH

    Find a price of Amiodarone Hydrochloride bulk offered by DKSH

    Find a price of Apixaban bulk offered by DKSH

    Find a price of Artemether bulk offered by DKSH

    Find a price of Aspirin bulk offered by DKSH

    Find a price of Atorvastatin bulk offered by DKSH

    Find a price of Atracurium Besylate bulk offered by DKSH

    Find a price of Avermectin bulk offered by DKSH

    Find a price of Azacitidine bulk offered by DKSH

    Find a price of Azathioprine bulk offered by DKSH

    Find a price of Azithromycin bulk offered by DKSH

    Find a price of Baloxavir Marboxil bulk offered by DKSH

    Find a price of Bortezomib bulk offered by DKSH

    Find a price of Bromhexine Hydrochloride bulk offered by DKSH

    Find a price of Budesonide bulk offered by DKSH

    Find a price of Carbamazepine bulk offered by DKSH

    Find a price of Carfilzomib bulk offered by DKSH

    Find a price of Carvedilol bulk offered by DKSH

    Find a price of Caspofungin bulk offered by DKSH

    Find a price of Chlorhexidine Gluconate bulk offered by DKSH

    Find a price of Cimetropium Bromide bulk offered by DKSH

    Find a price of Citicoline Sodium bulk offered by DKSH

    Find a price of Clarithromycin bulk offered by DKSH

    Find a price of Colchicine bulk offered by DKSH

    Find a price of Deferasirox bulk offered by DKSH

    Find a price of Desloratadine bulk offered by DKSH

    Find a price of Dexamethasone bulk offered by DKSH

    Find a price of Diclofenac Sodium bulk offered by DKSH

    Find a price of Dienogest bulk offered by DKSH

    Find a price of Digoxin bulk offered by DKSH

    Find a price of Diisopropylamine Dichloroacetate bulk offered by DKSH

    Find a price of Diphenhydramine Hydrochloride bulk offered by DKSH

    Find a price of Doxazosin Mesylate bulk offered by DKSH

    Find a price of Doxorubicin Hydrochloride bulk offered by DKSH

    Find a price of Doxycycline bulk offered by DKSH

    Find a price of Doxycycline Hyclate bulk offered by DKSH

    Find a price of Drospirenone bulk offered by DKSH

    Find a price of Emtricitabine bulk offered by DKSH

    Find a price of Epirubicin Hydrochloride bulk offered by DKSH

    Find a price of Erythromycin bulk offered by DKSH

    Find a price of Everolimus bulk offered by DKSH

    Find a price of Ezetimibe bulk offered by DKSH

    Find a price of Fluocinolone Acetonide bulk offered by DKSH

    Find a price of Gabapentin bulk offered by DKSH

    Find a price of Guaifenesin bulk offered by DKSH

    Find a price of Haloperidol bulk offered by DKSH

    Find a price of Icosapent Ethyl bulk offered by DKSH

    Find a price of Indacaterol Maleate bulk offered by DKSH

    Find a price of Indapamide bulk offered by DKSH

    Find a price of Itraconazole bulk offered by DKSH

    Find a price of Ivermectin bulk offered by DKSH

    Find a price of Ketotifen Fumarate bulk offered by DKSH

    Find a price of Lamivudine bulk offered by DKSH

    Find a price of Lamotrigine bulk offered by DKSH

    Find a price of Levocetirizine Dihydrochloride bulk offered by DKSH

    Find a price of Levofloxacin bulk offered by DKSH

    Find a price of Levofloxacin Hemihydrate bulk offered by DKSH

    Find a price of Lidamidine Hydrochloride bulk offered by DKSH

    Find a price of Lidocaine bulk offered by DKSH

    Find a price of Loratadine bulk offered by DKSH

    Find a price of Magaldrate bulk offered by DKSH

    Find a price of Magnesium Hydroxide bulk offered by DKSH

    Find a price of Mesalazine bulk offered by DKSH

    Find a price of Metaxalone bulk offered by DKSH

    Find a price of Methocarbamol bulk offered by DKSH

    Find a price of Methscopolamine Bromide bulk offered by DKSH

    Find a price of Methyl Salicylate bulk offered by DKSH

    Find a price of Metronidazole bulk offered by DKSH

    Find a price of Miconazole Nitrate bulk offered by DKSH

    Find a price of Mometasone Furoate bulk offered by DKSH

    Find a price of Mosapride Citrate bulk offered by DKSH

    Find a price of Moxifloxacin Hydrochloride bulk offered by DKSH

    Find a price of Mycophenolate Mofetil bulk offered by DKSH

    Find a price of Mycophenolate Mofetil Hydrochloride bulk offered by DKSH

    Find a price of Neomycin Sulfate bulk offered by DKSH

    Find a price of Nicorandil bulk offered by DKSH

    Find a price of Noscapine bulk offered by DKSH

    Find a price of Noscapine Hydrochloride bulk offered by DKSH

    Find a price of Olanzapine bulk offered by DKSH

    Find a price of Omega-3-Carboxylic Acids bulk offered by DKSH

    Find a price of Omeprazole bulk offered by DKSH

    Find a price of Paclitaxel bulk offered by DKSH

    Find a price of Pantoprazole Sodium bulk offered by DKSH

    Find a price of Papaverine Hydrochloride bulk offered by DKSH

    Find a price of Paracetamol bulk offered by DKSH

    Find a price of Paroxetine Hydrochloride bulk offered by DKSH

    Find a price of Pentosan Polysulfate Sodium bulk offered by DKSH

    Find a price of Pheniramine Maleate bulk offered by DKSH

    Find a price of Pranlukast Hydrate bulk offered by DKSH

    Find a price of Prednisone bulk offered by DKSH

    Find a price of Procaine bulk offered by DKSH

    Find a price of Quetiapine Hemifumarate bulk offered by DKSH

    Find a price of Rabeprazole Sodium bulk offered by DKSH

    Find a price of Racecadotril bulk offered by DKSH

    Find a price of Reserpine bulk offered by DKSH

    Find a price of Rosuvastatin Calcium bulk offered by DKSH

    Find a price of Ruxolitinib Phosphate bulk offered by DKSH

    Find a price of Salbutamol Sulphate bulk offered by DKSH

    Find a price of Scopolamine bulk offered by DKSH

    Find a price of Scopolamine Hydrobromide bulk offered by DKSH

    Find a price of Sirolimus bulk offered by DKSH

    Find a price of Sugammadex Sodium bulk offered by DKSH

    Find a price of Tacrolimus bulk offered by DKSH

    Find a price of Tadalafil bulk offered by DKSH

    Find a price of Tamsulosin bulk offered by DKSH

    Find a price of Telmisartan bulk offered by DKSH

    Find a price of Tenofovir Alafenamide Fumarate bulk offered by DKSH

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by DKSH

    Find a price of Tenoxicam bulk offered by DKSH

    Find a price of Terbinafine bulk offered by DKSH

    Find a price of Terbinafine Hydrochloride bulk offered by DKSH

    Find a price of Thiocolchicoside bulk offered by DKSH

    Find a price of Ulipristal Acetate bulk offered by DKSH

    Find a price of Vildagliptin bulk offered by DKSH

    Find a price of Vonoprazan Fumarate bulk offered by DKSH

    Find a price of Zoledronic Acid bulk offered by DKSH

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search